First Merchants (FRME) Q4 2025 Earnings Transcript

First Merchants reported record 2025 results with net income of $224.1 million, diluted EPS of $3.88 (+13.8% y/y), and record year-end assets, loans, and deposits. Net interest income rose $5.4 million sequentially to $145.3 million and NIM expanded 5 bps to 3.29%, though management expects only a couple of basis points of margin compression in 2026 as Fed cuts pressure yields. The bank also secured approvals for the $2.4 billion First Savings Group deal, plans to close on Feb. 1, 2026, and said it will remain aggressive on buybacks while capital stays strong.

Analysis

FRME is quietly setting up as a classic late-cycle bank compounding story: the near-term earnings engine is less about loan growth itself and more about spread capture from deposit repricing lagging asset repricing. The $800M of CDs rolling off at materially above current specials creates a temporary margin tailwind that should offset some Fed-driven loan yield pressure for the next two quarters, while the fixed-rate loan reset book adds another layer of support. That makes Q1/Q2 likely the cleanest earnings windows; by late 2026, the benefit becomes harder to see as the acquisition amortization and integration noise begin to dominate reported trends.

The more important second-order effect is capital deployment. Management is signaling that buybacks are the preferred use of incremental capital while the stock remains cheap, which creates a self-reinforcing EPS/TBV per share loop as long as credit stays contained. The acquisition further increases the odds of outsized repurchases because the pro forma capital ratio still appears above target even after closing, so the market may be underestimating how aggressively they can offset dilution and integration friction.

Credit is the main watch item, but the message is not deterioration so much as normalization in a more rate-sensitive commercial book. The sponsor finance loss and multifamily noise suggest the bank is now carrying more cyclical C&I/CRE risk than the headline reserve ratio implies, and that’s the tradeoff for the stronger loan growth profile. If charge-offs hold in the 15-20 bps range, the equity should work; if they drift higher while NIM compresses in 2H26, the stock likely de-rates quickly because the current story is very dependent on clean execution.

The contrarian angle is that consensus may be too focused on the acquisition headline and not enough on the underlying operating leverage. If management executes the CD repricing and fee-income growth plan, the stand-alone business can still compound while the deal becomes a bonus rather than a crutch. That said, once the market starts capitalizing the post-close cost base and softer 2026 margin, the multiple may stop re-rating until investors see proof that the promised synergies and buybacks translate into actual per-share accretion.

Key Decisions for Investors

• Long FRME common into the next 1-2 earnings prints, using pullbacks to add; thesis is that CD repricing and fixed-rate loan resets create a near-term margin tailwind that the market is not fully discounting.
• Pair trade: long FRME / short a more rate-sensitive Midwest regional with weaker deposit mix (e.g., CMA) over the next 3-6 months; FRME should have better EPS resilience if deposit betas stay favorable.
• Buy FRME Jan-2027 call spreads on weakness to express the view that buybacks plus acquisition synergies lift per-share earnings faster than the market expects; risk is that credit normalization offsets the synergy story.
• If already long, hedge with a partial short in a regional bank ETF or a weaker CRE-exposed name for the 2H26 period, when margin compression and integration expense should become more visible.
• Take profits on any post-close pop if the stock rerates to reflect pro forma capital deployment optimism before evidence of synergy capture; the setup is strongest in the next 2 quarters, not after integration noise peaks.